Osiris Therapeutics researches, develops, manufactures and commercializes regenerative medicine products that improve health and lives of patients and lower overall healthcare costs. Co. has products in orthopedics, sports medicine and wound care, including the Grafix product line, Stravix, BIO4 and Cartiform. Co. focuses on regenerative medicine including bioengineering, stem cell research and viable tissue based products. While Co. is focused on the development and commercialization of human cells, tissues and cellular and tissue-based products, Co. also has early discovery and development programs for biological product candidates, including its cellular drug program. We show 5 historical shares outstanding datapoints in our OSIR shares outstanding history coverage, used to compute OSIR market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing OSIR market cap history over the course of time is important for investors
interested in comparing OSIR's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of OSIR versus a peer is one thing; comparing
OSIR market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like OSIR can fluctuate over the course of history.
With this page we aim to empower investors researching OSIR by allowing them to research the OSIR market cap history. |
Free OSIR Email Alerts:
Video: The Importance of Market Cap
